BinderREFalingJPugatchRDMahasaenCSniderSL. Chronic necrotizing pulmonary aspergillosis: A discrete clinical entity. Medicine1982;61:109–24.
3.
KellyJKPintoARWhitelawWARorstadOPBrownTJMathesonDS. Fatal Aspergillus pneumonia in chronic granulomatous disease. Am J Clin Pathol1986;86:235–40.
4.
SchaffnerADouglasHBraudeA. Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. Observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes. J Clin Invest1982;69:617–31.
5.
WigginsJClarkTJHCorrinB. Chronic necrotising pneumonia caused by Aspergillus niger. Thorax1989;44:440–1.
6.
GeorgePJMBoffaPBJNaylorCPEHigenbottamTW. Necrotising pulmonary aspergillosis complicating the management of patients with obstructive airways disease. Thorax1983;38:478–80.
7.
BlumJReedJCPizzoSVThompsonMW. Miliary aspergillosis associated with alcoholism. Am J Radiol1978;131:707.
8.
CookDJAchongMRKingDEL. Disseminated aspergillosis in an apparently healthy patient. Am J Med1990;88:74–6.
9.
FischerJJWalkerDH. Invasive pulmonary aspergillosis associated with influenza. JAMA1979;241:1493–4.
RodenhuisSBeaumontFKauffmanHFSluiterHJ. Invasive pulmonary aspergillosis in a non-immunosuppressed patient: Successful management with systemic amphotericin and flucytosine and inhaled amphotericin. Thorax1984;39;78–9.
12.
ArroyoJMedoffBKobayashiGS. Therapy of murine aspergillosis with amphotericin 8 in combination with infection or 5 fluoroacytosine antimucous agents chemo treatment. Antimicrob Agents Chemother1977;11:21–5.
13.
DuPontBTrouhetE. The treatment of aspergillosis with azole derivatives. In: VandenBossche HBMackenzieDWRCauwengergHG, eds. Aspergillus and aspergillosis. New York: Plenum Press, 1988:243–51.